Regional chemotherapy for inoperable pancreatic carcinoma

Cancer

Volumn 78, Issue 3 SUPPL., 1996, Pages 664-673

  Muchmore, James H ^a   Preslan, Janet E ^a   George, William J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

extracorporeal hemofiltration; inoperable pancreatic cancer; regional arterial chemotherapy

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; HEMOFILTRATION; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; PANCREAS CARCINOMA; PRIORITY JOURNAL; REGIONAL PERFUSION;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MITOMYCIN; MITOXANTRONE; PANCREATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0029896569     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960801)78:3<664::AID-CNCR47>3.0.CO;2-U     Document Type: Article

References (52)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1995. Cancer 1996;46:5-27.
2. Krementz ET, Becker ML. Malignant diseases of the pancreas. Adv Surg 1972;6:205-36.
3. Fontham ETH, Correa P. Epidemiology of pancreatic cancer. Surg Clin N Am 1989;69:551-67.
4. Levin DL, Connelly RR. Cancer of the pancreas. Available epidemiologic information and its implications. Cancer 1973;31:1231-6.
5. Gudjonsson B. Cancer of the pancreas: 50 years of surgery. Cancer 1987;60:2284-303.
6. Menck HR, Garfinkel L, Dodd GD. Preliminary report of the National Cancer Data Base. Cancer 1991;41:7-18.
7. Brennan MF, Kinsella TJ, Casper ES. Cancer of the pancreas. In: DeVita VT Jr., Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia: JB Lippincott, 1993:849-82.
8. Gall FP, Kockerling F. The problem of radical surgery in pancreatic cancer and its implications for a combined-treatment approach. Recent Results Cancer Res 1988;110:79-86.
9. Cubilla AL, Fortner J, Fitzgerald PJ. Lymph node involvement in carcinoma of the head of the pancreas. Cancer 1978;41:880-7.
10. Nagakawa T, Kobayashi H, Ueno K, Ohta T, Kayahara M, Miyazaki I. Clinical study of the lymphatic flow to paraaortic lymph nodes in carcinoma of the head of the pancreas. Cancer 1994;73:1155-62.
11. Warshaw AL. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 1991;161:26-30.
12. Van Heerden JA, McJhath DC, Jlsrup DM, Weiland LH. Total pancreatectomy for ductal adenocarcinoma of the pancreas: an update. World J Surg 1988;12:658-62.
13. Martin JK Jr., Goellner JR. Abdominal fluid cytology in patients with gastrointestinal malignant lesions. Mayo Clin Proc 1986;61:467-71.
14. Griffin JF, Smalley SR, Jewell W, Paradelo JC, Reymond RD, Hassanein RES, et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990;66:56-61.
15. Kaiser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following a curative resection. Arch Surg 1985;120:899-903.
16. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following a curative resection of pancreatic cancer. Cancer 1987;59:2006-10.
17. Bengmark S, Andren-Sandberg A. Infusion chemotherapy in inoperable pancreatic carcinoma. Recent Research Cancer Res 1983;86:13-4.
18. Muchmore JH. Treatment of advanced pancreatic cancer with regional chemotherapy plus hemofiltration. Semin Surg Oncol 1995;11:154-67.
19. Aigner KR, Muller H, Bessermann R. Intra-arterial chemotherapy with MMC, CDDP and 5-FU for non-resectable pancreatic cancer - A phase II study. Reg Cancer Treat 1990; 3:1-6.
20. Dedrick RL, Oldfield EH, Collins JH. Arterial drug infusion with extracorporeal removal. Theoretical basis with particular reference to the brain. Cancer Treat Rep 1984;68:373-80.
21. Aigner KR, Thiller H, Walter H, Link KH. Drug nitration in high-dose regional chemotherapy. Contrib Oncol 1988; 29:261-80.
22. Muchmore JH, Krementz ET, Carter RD, Meyer GM, Preslan JE, George WJ. Management of advanced intra-abdominal malignancy using high-dose intra-arterial chemotherapy with concomitant hemofiltration. Reg Cancer Treat 1990; 3:211-5.
23. Muchmore JH, Krementz ET, Carter RD, Preslan JE, George WJ. Treatment of abdominal malignant neoplasms using regional chemotherapy with hemofiltration. Arch Surg 1991; 126:1390-6.
24. den Hartigh J, Van Orr WJ. High performance liquid chromatography determination of the anti-tumor agent Mitomycin C in human blood plasma. Anal Chim Acta 1981;127:47-53.
25. Stein TA, Burns GP, Bailey B, Wise L. Measurement of 5-fluorouracil and its metabolites in tissue. J Chromatoghr 1990;208:541-53.
26. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995;221:59-66.
27. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection margins in carcinoma of the head of the pancreas. Ann Surg 1993;217:144-8.
28. Hiraska T, Watanabe E, Mochinaga M, Tashiro S, Miyauchi Y, Nakamurs I, et al. Intraoperative radiation therapy for patients with pancreatic carcinoma. World J Surg 1984; 8:766-71.
29. Shipley WU, Tepper JC, Warshaw AL, Orlow EL. Intraoperative radiation therapy for patients with pancreatic carcinoma. World J Surg 1984;8:929-34.
30. Whittington R, Bryer MP, Haller DG, Solin LJ, Rosato EF, Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1991;21:1137-43.
31. Foo ML, Gunderson LL, Nagorney DM, McLlrath DC, van Heerden JA, Robinow JS, et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracil. Int J Radiat Oncol Biol Phys 1993;26:483-9.
32. Ishikawa O, Hiroaki O, Imaoka S, Saaki Y, Iwanaga T, Matayoshi Y, et al. Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? Arch Surg 1994; 129:1075-80.
33. Huffman JP, Weese JL, Solin LJ, Agarwal P, Engstrom P, Scher R, et al. A single institutional experience with preoperative chemoradiotherapy for Stage I-II pancreatic adenocarcinoma. Am Surg 1993;59:772-81.
34. Jessup JM, Steele G Jr., Mayer RJ, Posner M, Busse P, Cady B, et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 1993;128:559-64.
35. Carter SK. The integration of chemotherapy into a combined modality approach for cancer treatment: VI. Pancreatic adenocarcinoma. Cancer Treat Rev 1975;3:193-214.
36. Culliman S, Moertel CG, Wieand HS, Schutt AJ, Krook JE, Foley JF, et al. A phase III trial on the therapy of advanced pancreatic carcinoma. Cancer 1990;65:2207-12.
37. DeCaprio JA, Mayer RJ, Gonin R, Arbuck SG. Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of phase II trial. J Clin Oncol 1991;9:2128-33.
38. Goldstein LJ, Galski H, Fojo A, Willingham MC, Lai S-L, Gazdar A, et al. Expression of the multidrug resistance gene in human cancers. J Natl Cancer Inst 1989;81:116-24.
39. Almoquera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-54.
40. Capella G, Cronauer-Mitra S, Peinado MA, Perucho M. Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect 1991;93:125-31.
41. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 1993;142:1534-43.
42. Chin K-V, Ueda K, Pastan I, Gottesman MM. Modulation of the activity of the promoter of the human MDR1 gene by ras and p53. Science 1992;255:459-62.
43. Wu H, Little A. Perioperative blood transfusions and cancer recurrence. J Clin Oncol 1988;6:1348-54.
44. Foster RS Jr., Costanza MC, Foster JC. Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 1985;55:1195-201.
45. Crowe JP, Gordon NH, Fry DE, Shuck JM, Hubay CA, Breast cancer survival and perioperative blood transfusion. Surgery 1989;106:836-41.
46. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161:120-5.
47. Norman JG, Franz MG, Fink GS, Messina J, Fabri PJ, Gower WR, et al. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 1995;221:625-34.
48. Nakazaki H. Preoperative and postoperative cytokines in patients with cancer. Cancer 1992;70:709-13.
49. Moradi MM, Carson LF, Weinburg B, Haney AF, Twiggs LB, Ramakrishman S. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer 1993;72:2433-40.
50. Tyler DS, Evans DB. Reoperative pancreaticoduodenectomy. Ann Surg 1994;219:211-21.
51. Hellman S. Principles of radiation therapy. In: De Vita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: Principles & Practice of Oncology. 4th ed. Philadelphia: JB Lippincott 1993:248-75.
52. Aigner KR, Gailhofer S. Regional chemotherapy for nunresectable, locally metastasized pancreatic cancer - four studies including 164 cases. Reg Cancer Treat 1993;Suppl 1:A2.